Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone with GnRH Analogue Discontinuation in Metastatic Prostate Cancer
NCT03565835Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jun 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abiraterone in prostate cancer (PCa), sponsored by Montefiore Medical Center. Started Jun 2018; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03565835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565835.